Capillary Electrophoretic Enantiomeric Separations using the Glycopeptide Antibiotic, Teicoplanin
, 1996 Teicoplanin is the third in a series of macrocyclic glycopeptide antibiotics that has been evaluated as a chiral selector in capillary electrophoresis (CE). It was used to resolve over 100 anionic racemates at low selector concentrations.
Gasper, Mary P. +3 more
core +1 more source
Investigation of the rational use of teicoplanin in inpatient wards of teaching hospitals in Birjand, Iran, from 2022 to 2023 [PDF]
مجله دانشگاه علوم پزشکی بیرجندBackground and Aims: Incorrect and excessive use of antibiotics has led to a significant rise in drug resistance. Nowadays, irrational antibiotic use is a major contributor to increased illness, death, and healthcare costs.
Motahareh Mahi-Birjand +3 more
doaj
Chemical Tailoring of Teicoplanin with Site-Selective Reactions
, 2016 Semisynthesis of natural product derivatives combines the power of fermentation with orthogonal chemical reactions. Yet, chemical modification of complex structures represents an unmet challenge, as poor selectivity often undermines efficiency.
Scott J. Miller (1308798) +1 more
core +1 more source
The Comparison of Serum Teicoplanin Trough Concentrations Under Two Different Loading Doses
, 2007 研究背景：作為第一線治療多重抗藥性菌種所造成感染的重要抗生素之一，teicoplanin的療效取決於藥品濃度超過致病菌之最低抑制濃度（minimum inhibitory concentration，MIC）的時間長短，有鑑於臺灣近年格蘭氏陽性菌的抗藥性日益嚴重，臨床MRSA (methicillin-resistant Staphylococcus aureus)分離菌株對於teicoplanin的MIC逐漸增加至2 mg/L，藥品血中濃度建議至少維持在10 mg/L，甚至20 mg/L以上。然而 ...
Liao, Hsin-i, 廖欣誼
core
Long-term Treatment of Teicoplanin for Methicillin-resistant Staphylococcus aureus Sternal Osteomyelitis with Renal Impairment : A Case of High Teicoplanin Trough Levels Maintained by Therapeutic Drug Monitoring [PDF]
Teicoplanin, a glycopeptide antibiotic for methicillin-resistant Staphylococcus aureus, is recommended for therapeutic drug monitoring during treatment.
Higa, Futoshi +9 more
core
A review of the safety profile of teicoplanin
, 1991 Safety of teicoplanin has been assessed in 3377 patients treated in Europe up to the end of June 1990. One or more adverse events were experienced by 10 % of patients. Age and teicoplanin dose had no significant effect on the incidence or type of adverse
A. H. Williams, Peter G. Davey
core
Does the teicoplanin skin test predict IgE-mediated hypersensitivity? [PDF]
Allergol SelectBaştuğ İnan NB +3 more
europepmc +1 more source
Development and validation of an artificial intelligence-based model for predicting teicoplanin plasma concentrations in intensive care unit patients with pulmonary infections: a retrospective study. [PDF]
Int J Clin PharmZhang Q +8 more
europepmc +1 more source
Clinical outcomes of empirical anti-MRSA therapy at a tertiary care center in Madinah, Saudi Arabia: a retrospective single-center cohort study. [PDF]
BMC Infect DisAljohani F +6 more
europepmc +1 more source